← Back to headlines
BioNxt Provides Update on Sublingual Drug Delivery Pipeline
BioNxt has issued an update on the development, intellectual property, and commercial progress of its sublingual drug delivery pipeline, detailing advancements in its pharmaceutical projects.
17 Aug, 10:40 — 17 Aug, 10:40
Related Stories
AI Demand Fuels Record Chipmaker Profits Amid Broader Cost Pressures
2h ago
Rockstar Unveils Grand Theft Auto VI Details Ahead of Major Release
2h ago
Nvidia Reports Record Earnings and Raises Revenue Forecast Amid AI Demand Surge
3h ago
Trump Awards Congressional Space Medal of Honor to Artemis II Crew
4h ago